首页 > 最新文献

Archives of Medical Research最新文献

英文 中文
Response to: Comment on “Impaired Ischemia-Reperfusion Responses in the Hearts of Aged Male and Female Offspring of Obese Rats” 回应关于 "肥胖大鼠雌雄后代心脏缺血再灌注反应受损 "的评论
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-16 DOI: 10.1016/j.arcmed.2024.103111
Carlos A. Ibáñez , Elena Zambrano
{"title":"Response to: Comment on “Impaired Ischemia-Reperfusion Responses in the Hearts of Aged Male and Female Offspring of Obese Rats”","authors":"Carlos A. Ibáñez , Elena Zambrano","doi":"10.1016/j.arcmed.2024.103111","DOIUrl":"10.1016/j.arcmed.2024.103111","url":null,"abstract":"","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 2","pages":"Article 103111"},"PeriodicalIF":4.7,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142645297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive Frailty and Aging: Clinical Characteristics, Pathophysiological Mechanisms, and Potential Prevention Strategies 认知虚弱与衰老:临床特征、病理生理机制和潜在预防策略》(Cognitive Frailty and Aging: Clinical Characteristics, Pathophysiological Mechanisms, and Potential Prevention Strategies)。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-09 DOI: 10.1016/j.arcmed.2024.103106
Sara Gloria Aguilar-Navarro , Alberto José Mimenza-Alvarado , Sara Gabriela Yeverino-Castro , Sandra Milena Caicedo-Correa , Carlos Cano-Gutiérrez
Frailty has been conceptualized not only as a physical disease, but also as a multidomain entity that encompasses a multimorbid status, disability, cognitive impairment, psychosocial risk factors, and even geriatric syndromes. In addition to physical ailments and depending on the diagnostic model. Standardized neuropsychological tests can identify cognitive deficiencies along with mild cognitive impairment, a pre-dementia stage characterized by memory and/or other cognitive domain impairments with relatively preserved instrumental activities of daily living. Hence, the possibility of cognitive frailty (CF), a construct that refers to physical frailty in concurrence with non-dementia cognitive decline, is proposed. The estimated prevalence of CF ranges from 10.3 to 42.8%. It is likely that the pathway to overt cognitive impairment, which does not yet involve physical function, begins with the asymptomatic early accumulation of progressive brain damage. Thus, timely detection strategies that target the initial phases of CF are warranted. The pathophysiological components of CF include dysregulation of the hypothalamic-pituitary axis stress response, imbalance in energy metabolism, impaired cardiovascular function, mitochondrial deterioration, and vascular age-related arterial stiffness. Changes that contribute to this disease can also occur at the cellular level, including overexpression of the renin-angiotensin-aldosterone system, activation of proinflammatory pathways, endothelial dysfunction, reduced nitric oxide production, and increased oxidative stress. Non-pharmacological interventions, that range from dietary and nutritional counseling to psychosocial therapy, are currently the main approaches. Both cognitive and physical training programs are considered to be the best researched and most useful multidomain interventions. Clinicians recognize CF as a valid concept that warrants prevention and treatment strategies supported by current research.
虚弱不仅被视为一种身体疾病,也被视为一个多领域的实体,包括多病状态、残疾、认知障碍、社会心理风险因素,甚至老年综合症。除了躯体疾病外,根据诊断模式的不同。标准化的神经心理学测试可以发现认知缺陷和轻度认知功能障碍,轻度认知功能障碍是痴呆症的前期阶段,其特点是记忆力和/或其他认知领域受损,但日常生活的工具性活动相对保持不变。因此,有人提出了认知功能虚弱(CF)的可能性,这一概念是指身体虚弱与非痴呆认知功能衰退同时存在。据估计,认知虚弱的发病率在 10.3%至 42.8%之间。通往明显认知功能障碍(尚未涉及身体功能)的道路很可能始于无症状的渐进性脑损伤的早期积累。因此,针对 CF 初期阶段的及时检测策略是有必要的。CF 的病理生理学成分包括下丘脑-垂体轴应激反应失调、能量代谢失衡、心血管功能受损、线粒体退化以及与血管老化相关的动脉僵化。导致这种疾病的变化也可能发生在细胞层面,包括肾素-血管紧张素-醛固酮系统过度表达、促炎症途径激活、内皮功能障碍、一氧化氮生成减少和氧化应激增加。从饮食和营养咨询到社会心理治疗等非药物干预措施是目前的主要方法。认知和体能训练计划被认为是研究最充分、最有用的多领域干预措施。临床医生认为,CF 是一个有效的概念,需要有当前研究支持的预防和治疗策略。
{"title":"Cognitive Frailty and Aging: Clinical Characteristics, Pathophysiological Mechanisms, and Potential Prevention Strategies","authors":"Sara Gloria Aguilar-Navarro ,&nbsp;Alberto José Mimenza-Alvarado ,&nbsp;Sara Gabriela Yeverino-Castro ,&nbsp;Sandra Milena Caicedo-Correa ,&nbsp;Carlos Cano-Gutiérrez","doi":"10.1016/j.arcmed.2024.103106","DOIUrl":"10.1016/j.arcmed.2024.103106","url":null,"abstract":"<div><div>Frailty has been conceptualized not only as a physical disease, but also as a multidomain entity that encompasses a multimorbid status, disability, cognitive impairment, psychosocial risk factors, and even geriatric syndromes. In addition to physical ailments and depending on the diagnostic model. Standardized neuropsychological tests can identify cognitive deficiencies along with mild cognitive impairment, a pre-dementia stage characterized by memory and/or other cognitive domain impairments with relatively preserved instrumental activities of daily living. Hence, the possibility of cognitive frailty (CF), a construct that refers to physical frailty in concurrence with non-dementia cognitive decline, is proposed. The estimated prevalence of CF ranges from 10.3 to 42.8%. It is likely that the pathway to overt cognitive impairment, which does not yet involve physical function, begins with the asymptomatic early accumulation of progressive brain damage. Thus, timely detection strategies that target the initial phases of CF are warranted. The pathophysiological components of CF include dysregulation of the hypothalamic-pituitary axis stress response, imbalance in energy metabolism, impaired cardiovascular function, mitochondrial deterioration, and vascular age-related arterial stiffness. Changes that contribute to this disease can also occur at the cellular level, including overexpression of the renin-angiotensin-aldosterone system, activation of proinflammatory pathways, endothelial dysfunction, reduced nitric oxide production, and increased oxidative stress. Non-pharmacological interventions, that range from dietary and nutritional counseling to psychosocial therapy, are currently the main approaches. Both cognitive and physical training programs are considered to be the best researched and most useful multidomain interventions. Clinicians recognize CF as a valid concept that warrants prevention and treatment strategies supported by current research.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 1","pages":"Article 103106"},"PeriodicalIF":4.7,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of maternal hormone profile and paternal sperm DNA fragmentation on clinical outcomes following assisted reproduction 母体激素水平和父方精子 DNA 片段对辅助生殖临床结果的影响。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-09 DOI: 10.1016/j.arcmed.2024.103108
Khashayar Aflatoonian , Fatemehsadat Amjadi , Nadia Sheibak , Maryam Moradi , Abbas Aflatoonian , Maryamsadat Tabatabaei , Katayon Berjis , Reza Aflatoonian , Zahra Zandieh

Background

Success of assisted reproductive techniques depends on multiple factors including maternal endocrine status, hormonal balance, and paternal sperm quality. A comprehensive pre-treatment evaluation allows better prediction of outcomes and avoidance of unnecessary procedures and expenses.

Methods

To examine the impact of female hormonal profiles and sperm DNA damage on the success of assisted reproduction, medical data were extracted from the clinical records of infertile couples including couples’ age and levels of maternal anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL), as well as the DNA fragmentation index (DFI) in men. Any correlation between these parameters and clinical outcomes was investigated.

Results

DFI and FSH independently influenced the rate of high-quality embryos. A decrease in maternal age and PRL levels increased the rate of these embryos. On the other hand, an increase in maternal body mass index (BMI) or AMH levels was associated with a reduced chance of achieving high quality embryos. In addition, any reduction in PRL levels could be associated with a higher fertilization rate. FSH levels above the normal range contribute to a reduced rate of high-quality embryos. Overall, our findings demonstrate the complex interplay between different factors and their influence on fertilization success and emphasize the importance of optimizing these variables to achieve the best possible outcome.

Conclusion

Several factors can influence the outcome of infertility treatment. These factors include paternal DFI, maternal age, BMI, AMH, FSH, and PRL levels.
背景:辅助生殖技术的成功与否取决于多种因素,包括母体的内分泌状态、荷尔蒙平衡和父亲的精子质量。全面的治疗前评估可以更好地预测结果,避免不必要的程序和费用:为了研究女性荷尔蒙状况和精子 DNA 损伤对辅助生殖成功率的影响,我们从不孕夫妇的临床记录中提取了医疗数据,包括夫妇的年龄、母体抗穆勒氏管激素(AMH)、卵泡刺激素(FSH)、黄体生成素(LH)和催乳素(PRL)的水平,以及男性的 DNA 断裂指数(DFI)。研究还调查了这些参数与临床结果之间的相关性:结果:DFI 和 FSH 对优质胚胎率有独立影响。母体年龄和 PRL 水平的降低提高了优质胚胎率。另一方面,母体体重指数(BMI)或 AMH 水平的增加与获得优质胚胎的几率降低有关。此外,任何 PRL 水平的降低都可能与受精率的提高有关。FSH 水平超过正常范围会导致优质胚胎率降低。总之,我们的研究结果表明了不同因素之间复杂的相互作用及其对受精成功率的影响,并强调了优化这些变量以获得最佳结果的重要性:结论:有几个因素会影响不孕症治疗的结果。这些因素包括父亲的DFI、母亲的年龄、体重指数、AMH、FSH和PRL水平。
{"title":"Impact of maternal hormone profile and paternal sperm DNA fragmentation on clinical outcomes following assisted reproduction","authors":"Khashayar Aflatoonian ,&nbsp;Fatemehsadat Amjadi ,&nbsp;Nadia Sheibak ,&nbsp;Maryam Moradi ,&nbsp;Abbas Aflatoonian ,&nbsp;Maryamsadat Tabatabaei ,&nbsp;Katayon Berjis ,&nbsp;Reza Aflatoonian ,&nbsp;Zahra Zandieh","doi":"10.1016/j.arcmed.2024.103108","DOIUrl":"10.1016/j.arcmed.2024.103108","url":null,"abstract":"<div><h3>Background</h3><div>Success of assisted reproductive techniques depends on multiple factors including maternal endocrine status, hormonal balance, and paternal sperm quality. A comprehensive pre-treatment evaluation allows better prediction of outcomes and avoidance of unnecessary procedures and expenses.</div></div><div><h3>Methods</h3><div>To examine the impact of female hormonal profiles and sperm DNA damage on the success of assisted reproduction, medical data were extracted from the clinical records of infertile couples including couples’ age and levels of maternal anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL), as well as the DNA fragmentation index (DFI) in men. Any correlation between these parameters and clinical outcomes was investigated.</div></div><div><h3>Results</h3><div>DFI and FSH independently influenced the rate of high-quality embryos. A decrease in maternal age and PRL levels increased the rate of these embryos. On the other hand, an increase in maternal body mass index (BMI) or AMH levels was associated with a reduced chance of achieving high quality embryos. In addition, any reduction in PRL levels could be associated with a higher fertilization rate. FSH levels above the normal range contribute to a reduced rate of high-quality embryos. Overall, our findings demonstrate the complex interplay between different factors and their influence on fertilization success and emphasize the importance of optimizing these variables to achieve the best possible outcome.</div></div><div><h3>Conclusion</h3><div>Several factors can influence the outcome of infertility treatment. These factors include paternal DFI, maternal age, BMI, AMH, FSH, and PRL levels.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 8","pages":"Article 103108"},"PeriodicalIF":4.7,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142634093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of hormonal factors, number of sexual partners, surgical intervention on gastrointestinal and urogenital microbiota of patients endometriosis 激素因素、性伴侣数量、手术干预对子宫内膜异位症患者胃肠道和泌尿生殖道微生物群的影响
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-04 DOI: 10.1016/j.arcmed.2024.103112
Han Do , Paula Diaz-Sylvester , Kathleen Groesch , Teresa Wilson , Kristen Delfino , J.Ricardo Loret de Mola , Andrea Braundmeier-Fleming

Problem

Endometriosis is associated with gastrointestinal (GI) and urogenital (UG) microbial dysbiosis in patients with endometriosis (P-EOSIS). Sexual partner exposure may contribute to microbial dysbiosis but has not been studied in P-EOSIS. We hypothesized that sexual partner number, hormonal and surgical therapy would affect GI/UG microbial dysbiosis in P-EOSIS.

Methods of Study

Urine, fecal and vaginal swabs from control (n = 15) and P-EOSIS (n = 33) were collected on the day of surgery (DOS) and ∼1–3 weeks post-surgical intervention (PSI).
Control and P-EOSIS were grouped based on hormonal therapy (HT) to determine the effect of HT on microbial profiles, Control (HT n = 8; no HT n = 7) and P-EOSIS (HT n = 18; no HT n = 15). Samples underwent DNA extraction and sequencing of the V4 region of 16S rRNA gene. Sequences were processed using QIIME2 and amplicon sequence variants (ASV) were analyzed for microbial differences. Pearson's and Spearman correlation analyses determined associations among microbial features and sexual partner exposure.

Results

P-EOSIS had microbial dysbiosis characterized by unique GI/UG bacteria and altered microbial richness and diversity. Hormonal and surgical intervention in P-EOSIS restored GI microbial diversity. Increased sexual partner exposure decreased GI/UG microbial diversity. P-EOSIS who had 10 or more sexual partners had greater microbial dysbiosis compared to 4–6 partners. Surgical intervention negatively correlated with sexual partner numbers and GI/UG microbial abundance.

Discussion

Increased sexual partner exposure may enhance microbial dysbiosis in P-EOSIS and diminish the effectiveness of HT and surgical interventions.
问题子宫内膜异位症患者(P-EOSIS)的胃肠道(GI)和泌尿生殖道(UG)微生物菌群失调与子宫内膜异位症有关。性伴侣接触可能会导致微生物菌群失调,但尚未对 P-EOSIS 进行研究。我们假设性伴侣数量、激素和手术治疗会影响 P-EOSIS 的消化道/子宫内膜微生物菌群失调。研究方法在手术当天(DOS)和手术后 1-3 周(PSI)收集对照组(n = 15)和 P-EOSIS 组(n = 33)的尿液、粪便和阴道拭子。对照组和P-EOSIS组根据激素疗法(HT)分组,以确定HT对微生物特征的影响,对照组(HT n = 8;无HT n = 7)和P-EOSIS组(HT n = 18;无HT n = 15)。样本进行了 DNA 提取和 16S rRNA 基因 V4 区域测序。使用 QIIME2 对序列进行处理,并分析扩增子序列变异(ASV)以确定微生物差异。Pearson和Spearman相关性分析确定了微生物特征与性伴侣暴露之间的关联。对P-EOSIS进行激素和手术干预可恢复消化道微生物多样性。性伴侣接触增加会降低消化道/胃肠道微生物多样性。与 4-6 个性伴侣相比,有 10 个或更多性伴侣的 P-EOSIS 微生物菌群失调程度更高。手术干预与性伴侣数量和 GI/UG 微生物丰富度呈负相关。讨论性伴侣暴露增加可能会加重 P-EOSIS 微生物菌群失调,降低 HT 和手术干预的效果。
{"title":"Influence of hormonal factors, number of sexual partners, surgical intervention on gastrointestinal and urogenital microbiota of patients endometriosis","authors":"Han Do ,&nbsp;Paula Diaz-Sylvester ,&nbsp;Kathleen Groesch ,&nbsp;Teresa Wilson ,&nbsp;Kristen Delfino ,&nbsp;J.Ricardo Loret de Mola ,&nbsp;Andrea Braundmeier-Fleming","doi":"10.1016/j.arcmed.2024.103112","DOIUrl":"10.1016/j.arcmed.2024.103112","url":null,"abstract":"<div><h3>Problem</h3><div>Endometriosis is associated with gastrointestinal (GI) and urogenital (UG) microbial dysbiosis in patients with endometriosis (P-EOSIS). Sexual partner exposure may contribute to microbial dysbiosis but has not been studied in P-EOSIS. We hypothesized that sexual partner number, hormonal and surgical therapy would affect GI/UG microbial dysbiosis in P-EOSIS.</div></div><div><h3>Methods of Study</h3><div>Urine, fecal and vaginal swabs from control (<em>n</em> = 15) and P-EOSIS (<em>n</em> = 33) were collected on the day of surgery (DOS) and ∼1–3 weeks post-surgical intervention (PSI).</div><div>Control and P-EOSIS were grouped based on hormonal therapy (HT) to determine the effect of HT on microbial profiles, Control (HT <em>n</em> = 8; no HT <em>n</em> = 7) and P-EOSIS (HT <em>n</em> = 18; no HT <em>n</em> = 15). Samples underwent DNA extraction and sequencing of the V4 region of 16S rRNA gene. Sequences were processed using QIIME2 and amplicon sequence variants (ASV) were analyzed for microbial differences. Pearson's and Spearman correlation analyses determined associations among microbial features and sexual partner exposure.</div></div><div><h3>Results</h3><div>P-EOSIS had microbial dysbiosis characterized by unique GI/UG bacteria and altered microbial richness and diversity. Hormonal and surgical intervention in P-EOSIS restored GI microbial diversity. Increased sexual partner exposure decreased GI/UG microbial diversity. P-EOSIS who had 10 or more sexual partners had greater microbial dysbiosis compared to 4–6 partners. Surgical intervention negatively correlated with sexual partner numbers and GI/UG microbial abundance.</div></div><div><h3>Discussion</h3><div>Increased sexual partner exposure may enhance microbial dysbiosis in P-EOSIS and diminish the effectiveness of HT and surgical interventions.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 8","pages":"Article 103112"},"PeriodicalIF":4.7,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142578570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relevance of Circulating microRNA, and their Association with Islet Cell Autoantibodies in Type 1 Diabetes Pathogenesis 循环 microRNA 及其与 1 型糖尿病发病机制中胰岛细胞自身抗体的相关性。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-02 DOI: 10.1016/j.arcmed.2024.103114
Aritania S. Santos , Daniele Pereira Santos-Bezerra , Ludmila Rodrigues Pinto Ferreira , Silvia Y. Bando , Laís Isidoro Alves , Edecio Cunha-Neto , Maria Elizabeth Rossi da Silva

Background. Aims/hypothesis

The role of microRNAs (miRNAs) in the pathogenesis and progression of type 1 diabetes (T1D) has been described, but data remain scarce and conflicting.

Objectives

To evaluate the potential biological involvement of miRNA expression in the immune response and beta cell function in T1D.

Methods

We screened 10 serum miRNAs from 142 subjects divided into three groups: healthy individuals (control group; n = 52) and patients at different stages of T1D progression, from the initial immunological manifestation, presenting islet cell autoantibodies (AbP group; n = 39), to partial and severe beta cell damage in T1D (recent T1D group; n = 51).

Results

Three miRNAs (miR-200c-3p, miR-301a-3p, and miR-382–5p) were highly expressed in the AbP and/or recent T1D groups compared to the control group. Furthermore, in the AbP group, miR-301a-3p and miR-382–5p were positively correlated with insulin autoantibody levels and miR-382–5p was negatively correlated with C-peptide levels. In the recent T1D group, miR-200c-3p expression was positively correlated with IA-2A levels. Enrichment analysis of differentially expressed miRNAs showed their involvement in immune response, inflammatory pathways, proliferation/survival/apoptosis mechanisms, bacterial and viral infection, and insulin resistance.

Conclusion

Our data indicated that miR-200c-3p, miR-301a-3p, and miR-382–5p might be involved in T1D pathogenesis. Proliferative, metabolic, and immune responses were main pathways associated with serum miRNA target genes.
背景情况:目的/假设:微RNA(miRNA)在1型糖尿病(T1D)发病机制和进展中的作用已被描述,但数据仍然稀少且相互矛盾:评估 miRNA 表达在 T1D 免疫反应和 beta 细胞功能中的潜在生物学参与:我们筛选了 142 名受试者的 10 个血清 miRNA,分为三组:健康人(对照组;n = 52)和处于 T1D 进展不同阶段的患者,从最初的免疫学表现、出现胰岛细胞自身抗体(AbP 组;n = 39)到 T1D 中部分和严重的 beta 细胞损伤(近期 T1D 组;n = 51):结果:与对照组相比,三种 miRNA(miR-200c-3p、miR-301a-3p 和 miR-382-5p)在 AbP 组和/或近期 T1D 组中高表达。此外,在 AbP 组中,miR-301a-3p 和 miR-382-5p 与胰岛素自身抗体水平呈正相关,而 miR-382-5p 与 C 肽水平呈负相关。在近期 T1D 组中,miR-200c-3p 的表达与 IA-2A 水平呈正相关。对差异表达的 miRNA 进行的富集分析表明,它们参与了免疫反应、炎症通路、增殖/存活/凋亡机制、细菌和病毒感染以及胰岛素抵抗:我们的数据表明,miR-200c-3p、miR-301a-3p 和 miR-382-5p 可能参与了 T1D 的发病机制。增殖、代谢和免疫反应是与血清 miRNA 靶基因相关的主要途径。
{"title":"Relevance of Circulating microRNA, and their Association with Islet Cell Autoantibodies in Type 1 Diabetes Pathogenesis","authors":"Aritania S. Santos ,&nbsp;Daniele Pereira Santos-Bezerra ,&nbsp;Ludmila Rodrigues Pinto Ferreira ,&nbsp;Silvia Y. Bando ,&nbsp;Laís Isidoro Alves ,&nbsp;Edecio Cunha-Neto ,&nbsp;Maria Elizabeth Rossi da Silva","doi":"10.1016/j.arcmed.2024.103114","DOIUrl":"10.1016/j.arcmed.2024.103114","url":null,"abstract":"<div><h3>Background. Aims/hypothesis</h3><div>The role of microRNAs (miRNAs) in the pathogenesis and progression of type 1 diabetes (T1D) has been described, but data remain scarce and conflicting.</div></div><div><h3>Objectives</h3><div>To evaluate the potential biological involvement of miRNA expression in the immune response and beta cell function in T1D.</div></div><div><h3>Methods</h3><div>We screened 10 serum miRNAs from 142 subjects divided into three groups: healthy individuals (control group; <em>n</em> = 52) and patients at different stages of T1D progression, from the initial immunological manifestation, presenting islet cell autoantibodies (AbP group; <em>n</em> = 39), to partial and severe beta cell damage in T1D (recent T1D group; <em>n</em> = 51).</div></div><div><h3>Results</h3><div>Three miRNAs (miR-200c-3p, miR-301a-3p, and miR-382–5p) were highly expressed in the AbP and/or recent T1D groups compared to the control group. Furthermore, in the AbP group, miR-301a-3p and miR-382–5p were positively correlated with insulin autoantibody levels and miR-382–5p was negatively correlated with C-peptide levels. In the recent T1D group, miR-200c-3p expression was positively correlated with IA-2A levels. Enrichment analysis of differentially expressed miRNAs showed their involvement in immune response, inflammatory pathways, proliferation/survival/apoptosis mechanisms, bacterial and viral infection, and insulin resistance.</div></div><div><h3>Conclusion</h3><div>Our data indicated that miR-200c-3p, miR-301a-3p, and miR-382–5p might be involved in T1D pathogenesis. Proliferative, metabolic, and immune responses were main pathways associated with serum miRNA target genes.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 2","pages":"Article 103114"},"PeriodicalIF":4.7,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features and allele frequency of JAK2 Exon 12-mutated polycythemia vera in comparison with JAK2V617F-mutated disease JAK2外显子12突变型多发性红细胞症与JAK2V617F突变型多发性红细胞症的特征和等位基因频率对比。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-25 DOI: 10.1016/j.arcmed.2024.103109
Chin-hsuan Chuang , Ming-chung Kuo , Jin-hou Wu , Tung-liang Lin , Po-nan Wang , Yueh-shih Chang , Tung-hui Lin , Ting-yu Huang , Yu-shin Hung , Hsiao-wen Kao , Che-wei OU , Hung Chang , Lee-yung Shih

Background and Aim

JAK2 exon 12 mutation status and the clinical characteristics of patients with polycythemia vera (PV) in Asia remain to be defined.

Method

We analyzed the clinical, molecular, and genetic features and outcomes of patients with PV harboring exon 12 mutation and compared them with the JAK2V617F-mutated patients in Taiwan. JAK2V617F with allele burden was measured by pyrosequencing and/or RT/qPCR. The allele frequency of exon 12 mutation was analyzed by next-generation sequencing in JAK2V617F-negative patients.

Results

A total of 532 patients diagnosed with PV were enrolled. The JAK2V617F mutation was present in 94.9% and exon 12 mutations in 5.1%. At diagnosis, patients with exon 12 mutation had higher hemoglobin (p = 0.012), and hematocrit levels (p = 0.003), and lower platelet (p < 0.001), and leukocyte counts (p < 0.001) compared to patients with JAK2V617F mutations. Patients harboring the JAK2V617F mutation had a higher incidence of high allele burden (p < 0.001), disease risk (p = 0.014), and bleeding events (p = 0.013) compared to patients with PV with exon 12 mutations. These patients showed similar outcomes (overall survival, leukemia-free, myelofibrosis and thrombosis-free survival) to those with JAK2V617F mutations. An allele frequency ≥ 52.5% conferred an inferior overall survival compared to ≤ 52.5% in both exon 12-mutated (p = 0.029) and JAK2V617F patients with PV (p = 0.038).

Conclusion

Taiwanese patients with PV showed differences in blood count, risk group, and bleeding events between exon 12 and JAK2V617F patients. Higher mutant allele burden had a negative impact on overall survival for both mutation types.
背景与目的:亚洲多发性红细胞症(PV)患者的JAK2第12外显子突变状态和临床特征仍有待明确:我们分析了携带12号外显子突变的红细胞增多症患者的临床、分子和遗传特征及预后,并与台湾的JAK2V617F突变患者进行了比较。等位基因负荷的JAK2V617F是通过热测序和/或RT/qPCR测定的。通过新一代测序分析了JAK2V617F阴性患者外显子12突变的等位基因频率:结果:共纳入了 532 例确诊为 PV 的患者。94.9%的患者存在JAK2V617F突变,5.1%的患者存在12号外显子突变。诊断时,与JAK2V617F突变患者相比,外显子12突变患者的血红蛋白(p = 0.012)和血细胞比容水平(p = 0.003)较高,血小板(p < 0.001)和白细胞计数(p < 0.001)较低。与外显子12突变的PV患者相比,携带JAK2V617F突变的患者具有更高的高等位基因负担(p < 0.001)、疾病风险(p= 0.014)和出血事件(p= 0.013)发生率。这些患者的预后(总生存期、无白血病生存期、无骨髓纤维化生存期和无血栓形成生存期)与JAK2V617F突变患者相似。在外显子12突变(p = 0.029)和JAK2V617F突变(p = 0.038)的PV患者中,等位基因频率≥52.5%的总生存率低于≤52.5%的总生存率:结论:外显子12和JAK2V617F的台湾PV患者在血细胞计数、风险组别和出血事件方面存在差异。对于两种突变类型的患者而言,较高的突变等位基因负荷对总生存期均有负面影响。
{"title":"Features and allele frequency of JAK2 Exon 12-mutated polycythemia vera in comparison with JAK2V617F-mutated disease","authors":"Chin-hsuan Chuang ,&nbsp;Ming-chung Kuo ,&nbsp;Jin-hou Wu ,&nbsp;Tung-liang Lin ,&nbsp;Po-nan Wang ,&nbsp;Yueh-shih Chang ,&nbsp;Tung-hui Lin ,&nbsp;Ting-yu Huang ,&nbsp;Yu-shin Hung ,&nbsp;Hsiao-wen Kao ,&nbsp;Che-wei OU ,&nbsp;Hung Chang ,&nbsp;Lee-yung Shih","doi":"10.1016/j.arcmed.2024.103109","DOIUrl":"10.1016/j.arcmed.2024.103109","url":null,"abstract":"<div><h3>Background and Aim</h3><div><em>JAK2</em> exon 12 mutation status and the clinical characteristics of patients with polycythemia vera (PV) in Asia remain to be defined.</div></div><div><h3>Method</h3><div>We analyzed the clinical, molecular, and genetic features and outcomes of patients with PV harboring exon 12 mutation and compared them with the <em>JAK2</em>V617F-mutated patients in Taiwan. <em>JAK2</em>V617F with allele burden was measured by pyrosequencing and/or RT/qPCR. The allele frequency of exon 12 mutation was analyzed by next-generation sequencing in <em>JAK2</em>V617F-negative patients.</div></div><div><h3>Results</h3><div>A total of 532 patients diagnosed with PV were enrolled. The <em>JAK2</em>V617F mutation was present in 94.9% and exon 12 mutations in 5.1%. At diagnosis, patients with exon 12 mutation had higher hemoglobin (<em>p</em> = 0.012), and hematocrit levels (<em>p</em> = 0.003), and lower platelet (<em>p</em> &lt; 0.001), and leukocyte counts (<em>p</em> &lt; 0.001) compared to patients with <em>JAK2</em>V617F mutations. Patients harboring the <em>JAK2</em>V617F mutation had a higher incidence of high allele burden (<em>p</em> &lt; 0.001), disease risk (<em>p</em> <em>=</em> 0.014), and bleeding events <em>(p</em> <em>=</em> 0.013) compared to patients with PV with exon 12 mutations. These patients showed similar outcomes (overall survival, leukemia-free, myelofibrosis and thrombosis-free survival) to those with <em>JAK2</em>V617F mutations. An allele frequency ≥ 52.5% conferred an inferior overall survival compared to ≤ 52.5% in both exon 12-mutated (<em>p</em> = 0.029) and <em>JAK2</em>V617F patients with PV (<em>p</em> = 0.038).</div></div><div><h3>Conclusion</h3><div>Taiwanese patients with PV showed differences in blood count, risk group, and bleeding events between exon 12 and <em>JAK2</em>V617F patients. Higher mutant allele burden had a negative impact on overall survival for both mutation types.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 2","pages":"Article 103109"},"PeriodicalIF":4.7,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of hyperprolactinemia: General approach and reproductive health implications 高催乳素血症概述:一般方法和对生殖健康的影响。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-24 DOI: 10.1016/j.arcmed.2024.103102
Fabian Haidenberg-David, Jessica Sidauy-Adissi, Alberto Moscona-Nissan, Esbeydi Jonguitud-Zumaya, Montserrat Fugarolas-Morinelli, Florencia Martinez-Mendoza, Keiko Taniguchi-Ponciano, Daniel Marrero-Rodríguez, Moises Mercado
Prolactin (PRL) is a polypeptide hormone produced by the lactotrope cells of the anterior pituitary gland. Among its myriads of biological functions, PRL is the main regulator of mammary gland growth and development, as well as of the production and secretion of milk. Hyperprolactinemia represents a frequent consultation cause in medical practice. Nevertheless, elevations in serum PRL are not always pathological. Drug induced hyperprolactinemia is the most common cause, mainly by antipsychotics, followed by other causes such as pituitary neuroendocrine tumors, physiologic conditions, and systemic diseases such as chronic kidney disease and hypothyroidism. When evaluating a patient with hyperprolactinemia it is of utmost importance to consider the diverse etiologies of this condition in order to avoid unnecessary diagnostic workup and treatment. Regarding reproductive health, hyperprolactinemia is a well-documented cause of infertility, as approximately 15-20% of women undergoing infertility evaluation have hyperprolactinemia, which causes secondary amenorrhea, and other menstrual irregularities. Similarly, in men it is a cause of hypogonadism.
催乳素(PRL)是一种多肽激素,由垂体前叶的泌乳细胞产生。在其众多生物功能中,PRL 是乳腺生长和发育以及乳汁产生和分泌的主要调节因子。高催乳素血症是医疗实践中的常见病因。然而,血清 PRL 升高并不总是病态的。药物诱发的高泌乳素血症是最常见的原因,主要是抗精神病药物,其次是垂体神经内分泌肿瘤、生理性疾病和全身性疾病(如慢性肾病和甲状腺功能减退症)等其他原因。在对高催乳素血症患者进行评估时,最重要的是要考虑到这种病症的各种病因,以避免不必要的诊断工作和治疗。在生殖健康方面,高催乳素血症是导致不孕不育的一个有据可查的原因,在接受不孕不育评估的女性中,约有 15-20% 的人患有高催乳素血症,这会导致继发性闭经和其他月经不调。同样,它也是导致男性性腺功能减退的原因之一。
{"title":"Overview of hyperprolactinemia: General approach and reproductive health implications","authors":"Fabian Haidenberg-David,&nbsp;Jessica Sidauy-Adissi,&nbsp;Alberto Moscona-Nissan,&nbsp;Esbeydi Jonguitud-Zumaya,&nbsp;Montserrat Fugarolas-Morinelli,&nbsp;Florencia Martinez-Mendoza,&nbsp;Keiko Taniguchi-Ponciano,&nbsp;Daniel Marrero-Rodríguez,&nbsp;Moises Mercado","doi":"10.1016/j.arcmed.2024.103102","DOIUrl":"10.1016/j.arcmed.2024.103102","url":null,"abstract":"<div><div>Prolactin (PRL) is a polypeptide hormone produced by the lactotrope cells of the anterior pituitary gland. Among its myriads of biological functions, PRL is the main regulator of mammary gland growth and development, as well as of the production and secretion of milk. Hyperprolactinemia represents a frequent consultation cause in medical practice. Nevertheless, elevations in serum PRL are not always pathological. Drug induced hyperprolactinemia is the most common cause, mainly by antipsychotics, followed by other causes such as pituitary neuroendocrine tumors, physiologic conditions, and systemic diseases such as chronic kidney disease and hypothyroidism. When evaluating a patient with hyperprolactinemia it is of utmost importance to consider the diverse etiologies of this condition in order to avoid unnecessary diagnostic workup and treatment. Regarding reproductive health, hyperprolactinemia is a well-documented cause of infertility, as approximately 15-20% of women undergoing infertility evaluation have hyperprolactinemia, which causes secondary amenorrhea, and other menstrual irregularities. Similarly, in men it is a cause of hypogonadism.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 8","pages":"Article 103102"},"PeriodicalIF":4.7,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lethal synergistic infections by two concurrent respiratory pathogens 两种并发呼吸道病原体的致命协同感染。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-24 DOI: 10.1016/j.arcmed.2024.103101
Kevin Roe
Lethal synergistic infections by concurrent pathogens have occurred in humans, including human immunodeficiency virus and Mycobacterium tuberculosis infections, or in animal or human models of influenza virus, or bacteria, e.g., Streptococcus pneumoniae, concurrent with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2). However, the intracellular synergistic interaction possibilities between two respiratory viral pathogens, or between viral and fungal pathogens, merits additional examination. The requirements for synergistic concurrent pathogen infections are: a) relatively little detrimental interference between two pathogens, b) one pathogen having the capability of directly or indirectly assisting the second pathogen by direct immuno–manipulation or indirect provision of infection opportunities and/or metabolic assistance, c) substantial human or environmental prevalence, possibly including a prevalence in any type of health–care facilities or other locations having congregations of potentially infected human or animal vectors and d) substantial transmissibility of the pathogens, which would make their concurrent pathogen infections much more probable. A new definition of pathogen synergy is proposed: “pathogen synergy is an interaction of two or more pathogens during concurrent infections causing an increased infection severity compared to mono–infections by the individual pathogens.” Non–respiratory pathogens can also concurrently infect organs besides the lungs. However, the air–transmissible respiratory pathogens, particularly the RNA viruses, can enable highly widespread and synergistic concurrent infections. For instance, certain strains of coronaviruses, influenza viruses and similar respiratory viruses, are highly transmissible and/or widely prevalent in various vectors for transmission to humans and have numerous capabilities for altering lung immune defenses.
人类曾发生过同时感染病原体的致命协同感染,包括人类免疫缺陷病毒和结核分枝杆菌感染,或在流感病毒或细菌(如肺炎链球菌)与严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)同时感染的动物或人类模型中。然而,两种呼吸道病毒病原体之间或病毒与真菌病原体之间的细胞内协同作用可能性值得进一步研究。病原体同时协同感染的条件是a) 两种病原体之间的有害干扰相对较小;b) 一种病原体有能力通过直接免疫操纵或间接提供感染机会和/或代谢协助,直接或间接协助第二种病原体;c) 在人类或环境中大量流行,可能包括在任何类型的医疗保健设施或其他有可能受感染的人类或动物载体聚集的地方流行;d) 病原体的大量传播,这将使它们同时发生病原体感染的可能性大大增加。提出了病原体协同作用的新定义:"病原体协同作用是指两种或两种以上病原体在同时感染过程中相互作用,导致感染严重程度高于单种病原体的单一感染。除肺部外,非呼吸道病原体也可同时感染其他器官。然而,可通过空气传播的呼吸道病原体,尤其是 RNA 病毒,可造成高度广泛和协同的并发感染。例如,冠状病毒、流感病毒和类似呼吸道病毒的某些毒株具有高度传播性和/或广泛流行于各种载体,可传播给人类,并具有改变肺部免疫防御系统的多种能力。
{"title":"Lethal synergistic infections by two concurrent respiratory pathogens","authors":"Kevin Roe","doi":"10.1016/j.arcmed.2024.103101","DOIUrl":"10.1016/j.arcmed.2024.103101","url":null,"abstract":"<div><div>Lethal synergistic infections by concurrent pathogens have occurred in humans, including human immunodeficiency virus and <em>Mycobacterium tuberculosis</em> infections, or in animal or human models of influenza virus, or bacteria, e.g., <em>Streptococcus pneumoniae</em>, concurrent with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2). However, the intracellular synergistic interaction possibilities between two respiratory viral pathogens, or between viral and fungal pathogens, merits additional examination. The requirements for synergistic concurrent pathogen infections are: a) relatively little detrimental interference between two pathogens, b) one pathogen having the capability of directly or indirectly assisting the second pathogen by direct immuno–manipulation or indirect provision of infection opportunities and/or metabolic assistance, c) substantial human or environmental prevalence, possibly including a prevalence in any type of health–care facilities or other locations having congregations of potentially infected human or animal vectors and d) substantial transmissibility of the pathogens, which would make their concurrent pathogen infections much more probable. A new definition of pathogen synergy is proposed: “pathogen synergy is an interaction of two or more pathogens during concurrent infections causing an increased infection severity compared to mono–infections by the individual pathogens.” Non–respiratory pathogens can also concurrently infect organs besides the lungs. However, the air–transmissible respiratory pathogens, particularly the RNA viruses, can enable highly widespread and synergistic concurrent infections. For instance, certain strains of coronaviruses, influenza viruses and similar respiratory viruses, are highly transmissible and/or widely prevalent in various vectors for transmission to humans and have numerous capabilities for altering lung immune defenses.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 1","pages":"Article 103101"},"PeriodicalIF":4.7,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening public health systems during an emerging respiratory disease pandemic: A realist review 在新出现的呼吸道疾病大流行期间加强公共卫生系统:现实主义审查。
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-24 DOI: 10.1016/j.arcmed.2024.103096
Zahra Afshar Hosseinabadi , Mostafa Amini-Rarani , Mohammadreza Amiresmaili , Nasrin Shaarbafchizadeh , Ahmad Reza Raeisi
The recent outbreak of respiratory diseases such as COVID-19 has highlighted the need to strengthen public health systems to respond effectively to such crises. While previous research has identified various public health interventions for pandemics, there remains a significant gap in understanding which interventions can strengthen public health systems during emerging respiratory pandemics and under what conditions. To address this gap, we conducted a realist review to examine public health interventions during emerging respiratory disease pandemics, focusing on context, mechanisms, and outcomes. We conducted a literature search across PubMed, Scopus, ProQuest, and Web of Science for studies published since 2003. Finally, we analyzed and assessed the quality of 601 articles and analyzed 32 of them.
This study emphasizes the importance of understanding the situational, structural, cultural, and environmental contexts that influence public health interventions within the six building blocks of public health systems. We have also identified the mechanisms of these interventions at the individual, organizational, and national levels for successful outcomes, such as improved access to health services, health equity, and effectiveness.
This information is important for policymakers and practitioners who can use it to develop evidence-based strategies to strengthen public health systems during emerging respiratory disease pandemics. Our review introduced a new conceptual model to explore the interaction between context, interventions, mechanisms, and outcomes to strengthen public health systems. However, further research is needed to determine the effect of specific contextual factors on public health system interventions during respiratory disease pandemics.
最近爆发的 COVID-19 等呼吸道疾病凸显了加强公共卫生系统有效应对此类危机的必要性。虽然以往的研究已确定了针对大流行病的各种公共卫生干预措施,但在了解哪些干预措施可在新出现的呼吸道大流行病期间以及在何种条件下加强公共卫生系统方面仍存在巨大差距。为了弥补这一差距,我们进行了一次现实主义综述,研究新出现的呼吸道疾病大流行期间的公共卫生干预措施,重点关注背景、机制和结果。我们在 PubMed、Scopus、ProQuest 和 Web of Science 上对 2003 年以来发表的研究进行了文献检索。最后,我们对 601 篇文章进行了分析和质量评估,并对其中 32 篇文章进行了分析。本研究强调了在公共卫生系统的六个组成部分中,了解影响公共卫生干预的情景、结构、文化和环境背景的重要性。我们还确定了这些干预措施在个人、组织和国家层面取得成功结果的机制,如改善卫生服务的获取、卫生公平性和有效性。这些信息对政策制定者和从业人员非常重要,他们可以利用这些信息制定循证策略,在新出现的呼吸道疾病流行期间加强公共卫生系统。我们的综述引入了一个新的概念模型,以探索背景、干预措施、机制和结果之间的相互作用,从而加强公共卫生系统。不过,还需要进一步研究,以确定具体环境因素对呼吸道疾病流行期间公共卫生系统干预措施的影响。
{"title":"Strengthening public health systems during an emerging respiratory disease pandemic: A realist review","authors":"Zahra Afshar Hosseinabadi ,&nbsp;Mostafa Amini-Rarani ,&nbsp;Mohammadreza Amiresmaili ,&nbsp;Nasrin Shaarbafchizadeh ,&nbsp;Ahmad Reza Raeisi","doi":"10.1016/j.arcmed.2024.103096","DOIUrl":"10.1016/j.arcmed.2024.103096","url":null,"abstract":"<div><div>The recent outbreak of respiratory diseases such as COVID-19 has highlighted the need to strengthen public health systems to respond effectively to such crises. While previous research has identified various public health interventions for pandemics, there remains a significant gap in understanding which interventions can strengthen public health systems during emerging respiratory pandemics and under what conditions. To address this gap, we conducted a realist review to examine public health interventions during emerging respiratory disease pandemics, focusing on context, mechanisms, and outcomes. We conducted a literature search across PubMed, Scopus, ProQuest, and Web of Science for studies published since 2003. Finally, we analyzed and assessed the quality of 601 articles and analyzed 32 of them.</div><div>This study emphasizes the importance of understanding the situational, structural, cultural, and environmental contexts that influence public health interventions within the six building blocks of public health systems. We have also identified the mechanisms of these interventions at the individual, organizational, and national levels for successful outcomes, such as improved access to health services, health equity, and effectiveness.</div><div>This information is important for policymakers and practitioners who can use it to develop evidence-based strategies to strengthen public health systems during emerging respiratory disease pandemics. Our review introduced a new conceptual model to explore the interaction between context, interventions, mechanisms, and outcomes to strengthen public health systems. However, further research is needed to determine the effect of specific contextual factors on public health system interventions during respiratory disease pandemics.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 2","pages":"Article 103096"},"PeriodicalIF":4.7,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: “Impaired Ischemia-Reperfusion Responses in the Hearts of Aged Male and Female Offspring of Obese Rats” 评论"肥胖大鼠雌雄后代心脏缺血再灌注反应受损
IF 4.7 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-10-22 DOI: 10.1016/j.arcmed.2024.103110
Eduardo Perez-Campos , Laura Pérez-Campos Mayoral , María Teresa Hernández-Huerta , Hector A. Cabrera-Fuentes
{"title":"Comment on: “Impaired Ischemia-Reperfusion Responses in the Hearts of Aged Male and Female Offspring of Obese Rats”","authors":"Eduardo Perez-Campos ,&nbsp;Laura Pérez-Campos Mayoral ,&nbsp;María Teresa Hernández-Huerta ,&nbsp;Hector A. Cabrera-Fuentes","doi":"10.1016/j.arcmed.2024.103110","DOIUrl":"10.1016/j.arcmed.2024.103110","url":null,"abstract":"","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 2","pages":"Article 103110"},"PeriodicalIF":4.7,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Medical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1